A therapeutic DC vaccine with maintained immunological activity exhibits robust anti-tumor efficacy.
Lu Y, Shi Y, Liu Y, Luo Z, Zhang J, Jiang M, Li X, Liu X, Guo X, Qin B, Yin H, Du Y, Qiu Y, Lou Y, Guan G, Luo L, You J.
Lu Y, et al. Among authors: zhang j.
J Control Release. 2022 Sep;349:254-268. doi: 10.1016/j.jconrel.2022.06.059. Epub 2022 Jul 9.
J Control Release. 2022.
PMID: 35803328